Gábor Lovas

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

James F. Howard, Kimiaki Utsugisawa, Michael Benatar et al. · The Lancet Neurology · 2017 · 800 citations

Medicine, Pharmacology, Pharmacotherapy +6

Axonal changes in chronic demyelinated cervical spinal cord plaques

Gábor Lovas, Nóra Szilágyi, Katalin Majtényi et al. · Brain · 2000 · 357 citations · Full text

Life Sciences, Neurology, Neuroscience +17

The Neuroprotective Functions of Transforming Growth Factor Beta Proteins

Árpád Dobolyi, Csilla Vincze, Gabriella Pál et al. · International Journal of Molecular Sciences · 2012 · 257 citations · Full text

Life Sciences, Neurobiology, Neuroscience +16

Post-intervention Status in Patients With Refractory Myasthenia Gravis Treated With Eculizumab During REGAIN and Its Open-Label Extension

Renato Mantegazza, Gil I. Wolfe, Srikanth Muppidi et al. · Neurology · 2020 · 79 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +9

Eculizumab improves fatigue in refractory generalized myasthenia gravis

Henning Andersen, Renato Mantegazza, Jing Jing Wang et al. · Quality of Life Research · 2019 · 56 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14